KalmanDMorrisetteSBGeorgeTP. Co-morbidity of smoking with psychiatric and substance use disorders. Am J Addict. 2005;14:106–123.
2.
LasserKBoydJWWoolhanderS, Smoking and mental illness: A population-based prevalence study. JAMA. 2000;284:2606–2610.
3.
ZiedonisDHitsmanBBeckhamJC, Tobacco use cessation in psychiatric disorders: National Institute of Mental Health (NIMH) report. Nicotine Tob Res. 2008;10:1691–1715.
4.
HennekensCHHennekensARHollarD, Schizophrenia and increased risk of cardiovascular disease. Am Heart J. 2005;150:1115–1121.
5.
HserYIMcCarthyWJAnglinMD. Tobacco use as a distal predictor of mortality among long-term narcotic addicts. Prev Med. 1994;23:61–69.
6.
BrownSInskipHBarracloughB.Causes of excess mortality in schizophrenia. Br J Psychiatry. 2000;177:212–217.
7.
HurtRDOffordKPCroghanIT, Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA. 1996;275:1097–1103.
8.
MorisanoDBacherIAudrain-McGovernJ, Mechanisms underlying the comorbidity of tobacco use in mental health and addictive disorders. Can J Psychiatry. 2009;54(6):356–367.
9.
AdlerLEHofferLDWiserA, Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry. 1993;150:1856–1861.
10.
GeorgeTPTermineASaccoKA, Effects of cigarette smoking on prepulse inhibition in schizophrenia: Involvement of nicotinic receptor mechanisms. Schizophr Res. 2006;87:307–315.
11.
SaccoKATermineASeyalAA, Effects of cigarette smoking function on spatial working memory and attentional function in schizophrenia: Involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry. 2005;62:649–659.
12.
GeorgeTPVessicchioJCSaccoKA, Nicotinic antagonist augmentation of SSRI antidepressants in major depressive disorder: A preliminary study. J Clin Psychopharmacol. 2008;28:340–344.
13.
Salin-PascualRJRosasMJimenez-GenchiA, Antidepressant effect of transdermal nicotine patches in non-smoking patients with major depression. J Clin Psychiatry. 1996;57:387–389.
14.
ThorsteinssonHSGillinJCPattenCA, The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression. Neuropsychopharmacology. 2001;24:350–358.
15.
WilliamsJM. Eliminating tobacco use in mental health facilities: Patients' rights, public health, and policy issues. JAMA. 2008;299:571–573.
16.
HitsmanBMossTGMontoyaID, Treatment of tobacco dependence in mental health and addictive disorders. Can J Psychiatry. 2009;54(6):368–378.
17.
HallSMHumfleetGLReusVI, Extended nortriptyline and psychological treatment for cigarette smoking. Am J Psychiatry. 2004;161:2100–2107.
18.
McFallMSaxonAJThompsonCE, Improving the rates of quitting smoking for veterans with posttraumatic stress disorder. Am J Psychiatry. 2005;162:1311–1319.
19.
EvinsAECatherCCulhaneMA, A 12-week double-blind, placebo-controlled study of bupropion added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. J Clin Psychopharmacol. 2007;27:380–386.
20.
GeorgeTPVessicchioJCSaccoKA, A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia. Biol Psychiatry. 2008;63:1092–1096.
21.
Le FollBGeorgeTP. Treatment of tobacco dependence: Integrating recent progress into practice. CMAJ. 2007;177:1373–1380.
22.
McChargueDEGulliverSBHitsmanB.Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment?Addiction. 2002;97:785–793.
23.
AppelbaumPS. Do hospitalized patients have a right to smoke?Psychiatr Serv. 1995;46:653–654.
24.
LawnSPolsR.Smoking bans in psychiatric inpatient settings? A review of the research. Aust N Z J Psychiatry. 2005;39:866–885.
25.
ZiedonisDMZammarelliLSewardG, Addressing tobacco use through organizational change: A case study of an addiction treatment organization. J Psychoactive Drugs. 2007;39:451–459.
MontoyaIDHerbeckDMSviksDS, Identification and treatment of patients with nicotine problems in routine clinical psychiatry practice. Am J Addict. 2005;14:441–454.
28.
ChengappaKNKambhampatiRKPerkinsK, Bupropion sustained-release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitors. J Clin Psychiatry. 2001;62:503–508.
29.
WeinbergerAHVessicchioJCSaccoKA, A preliminary study of sustained-release bupropion for smoking cessation in bipolar disorder. J Clin Psychopharmacol. 2008;28:584–587.